Ftse Mib
34.517,07
-0,88%
DAX
18.689,36
-0,41%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.021,89
-0,60%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Windtree Therapeutics Inc (WINT) Windtree Therapeutics Inc (WINT) Notizie

WINT

Windtree Therapeutics (WINT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:WINT
DataOraFonteTitoloSimboloCompagnia
15/05/202422:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WINTWindtree Therapeutics Inc
09/05/202414:41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
07/05/202414:00GlobeNewswire Inc.Windtree Therapeutics Regains Compliance with NasdaqNASDAQ:WINTWindtree Therapeutics Inc
18/04/202414:00GlobeNewswire Inc.Windtree Therapeutics Announces Reverse Stock SplitNASDAQ:WINTWindtree Therapeutics Inc
17/04/202414:00GlobeNewswire Inc.Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
08/04/202422:48GlobeNewswire Inc.Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge FinancingNASDAQ:WINTWindtree Therapeutics Inc
16/02/202423:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WINTWindtree Therapeutics Inc
14/02/202423:23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:WINTWindtree Therapeutics Inc
14/02/202422:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WINTWindtree Therapeutics Inc
12/02/202422:40Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202423:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:WINTWindtree Therapeutics Inc
01/02/202414:00GlobeNewswire Inc.Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a ResearchNASDAQ:WINTWindtree Therapeutics Inc
31/01/202414:40InvestorsHub NewsWireWindtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic AlternativesNASDAQ:WINTWindtree Therapeutics Inc
25/01/202415:04InvestorsHub NewsWireWindtree Eliminates $15 Million Contingent Liability to Deerfield Management CompanyNASDAQ:WINTWindtree Therapeutics Inc
17/01/202414:00GlobeNewswire Inc.Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific RegionNASDAQ:WINTWindtree Therapeutics Inc
16/01/202422:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WINTWindtree Therapeutics Inc
02/01/202422:05GlobeNewswire Inc.Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a ActivatorNASDAQ:WINTWindtree Therapeutics Inc
18/12/202314:00GlobeNewswire Inc.Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockNASDAQ:WINTWindtree Therapeutics Inc
16/11/202314:00GlobeNewswire Inc.Windtree Therapeutics Announces Issuance of New Pure SERCA2a Activator PatentNASDAQ:WINTWindtree Therapeutics Inc
09/11/202322:15GlobeNewswire Inc.Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
08/11/202314:00GlobeNewswire Inc.Windtree to Present at the Sidoti Micro Cap Conference on November 16thNASDAQ:WINTWindtree Therapeutics Inc
12/10/202313:30GlobeNewswire Inc.Windtree to Present at the ThinkEquity Conference on October 19th in New York CityNASDAQ:WINTWindtree Therapeutics Inc
10/10/202313:30GlobeNewswire Inc.Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17thNASDAQ:WINTWindtree Therapeutics Inc
03/10/202314:00GlobeNewswire Inc.Windtree to Present at the Dawson James Small Cap Growth Conference on October 12thNASDAQ:WINTWindtree Therapeutics Inc
28/09/202313:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WINTWindtree Therapeutics Inc
21/09/202315:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:WINTWindtree Therapeutics Inc
06/09/202301:21Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:WINTWindtree Therapeutics Inc
30/08/202322:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:WINTWindtree Therapeutics Inc
23/08/202314:00GlobeNewswire Inc.Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark OfficeNASDAQ:WINTWindtree Therapeutics Inc
07/08/202322:05GlobeNewswire Inc.Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business UpdatesNASDAQ:WINTWindtree Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:WINT

La tua Cronologia

BIT
SPM
Saipem
BIT
G
Generali
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BPE
Bper Banca
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
CPR
Davide Campari
BIT
TEN
Tenaris
BIT
BPSO
Banca Popolare di Sondrio
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network